BELLEVUE, Wash., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Today, Truveta announced a strategic collaborative agreement with Boston Scientific to improve long-term patient care and gain insights into healthcare disparities. Through this collaboration, Boston Scientific researchers will be able to access data from Truveta, which contains de-identified medical records from more than 65 million U.S. patients.
"Truveta will enable us to gather insights on a breadth of devices and disease states, including peripheral artery disease, venous thromboembolic disease, and segments of interventional oncology," said Michael R. Jaff, D.O., vascular medicine specialist and chief medical officer and vice president, Medical Affairs, Innovation...